Abstract
Alzheimer’s disease (AD) GWASdb genes (N=1591) were analysed for enrichment versus other disease genes or the host genes of 18 host/pathogen interactomes (viral, bacterial, fungal and protozoan). AD gene/Chemical enrichment was analysed using the Comparative Toxicogenomics Database. AD incidence inversely associates with cancer and AD genes are enriched in cancer genes and in genes affected by carcinogenic or antineoplastic agents. Host/pathogen interactomes were enriched in AD genes, which were also targeted by mycotoxins. Many cancers are pathogen-related. AD genes may convey resistance to pathogens and the Cancer/AD inversion may pivot around this effect. AD genes were enriched in genes for type 2 diabetes, cardiovascular diseases, lipid metabolism disorders, arteriosclerosis, obesity, mood disorders and immune system or infectious diseases. Genes affected by NSAID’s and statins or antidiabetic drugs (PPAR ligands) and dietary polyphenols (all with antimicrobial activity) were also enriched in AD genes. Other drugs targeting AD genes affect sex steroids, retinoid and thyroid hormones and include immunosuppressants and anticonvulsants. AD genes were enriched in genes related to 28 endogenous compounds (retinoids, estrogens, progesterone, corticosterone, calcitriol, vitamins C and D3, folate, methionine and choline, an endogenous aryl hydrocarbon receptor ligand (ITE) and compounds related to oxidative stress. Most could be linked to immune regulation and many, like beta-amyloid, have antimicrobial properties (N-acetyl cysteine, Glutathione, Lithocholic acid, melatonin, Nitric oxide, iron/ascorbic acid, iron/O2 , H2O2, arachidonic and hypochlorous acids) These compounds selectively target immune and pathogen pathways. AD genes were also enriched in genes affected by AD risk factors (dietary fats/sucrose, pesticides, metals, vehicle emissions or smoking and other pollutants. The analysis highlights AD gene subsets related to AD comorbidities, risk factors or beneficial agents. Endogenous